Stay updated on Talque & Teclistamab Combo in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.

Latest updates to the Talque & Teclistamab Combo in Myeloma Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA recruitment status was updated to 'No longer looking for participants' with a returned date of 2026-06-12, and several study-result sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) were added alongside a Quality Control status. The record now shows Revision: v3.6.0 and notes the removal of the older v3.5.5, signaling an updated data review process.SummaryDifference0.7%

- Check17 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, reflecting a minor build or interface update on the study history page.SummaryDifference0.0%

- Check39 days agoChange DetectedA new revision entry v3.5.4 was added to the study's record history, updating the version shown and replacing the previous v3.5.3.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page footer shows a new ClinicalTrials.gov site revision number (updating from v3.5.2 to v3.5.3), reflecting a platform/version update rather than a change to the study record itself.SummaryDifference0.0%

- Check67 days agoChange DetectedThe history shows a new revision v3.5.2 added and v3.5.0 removed, indicating a minor version update to the page.SummaryDifference0.0%

- Check74 days agoChange DetectedNew sections for Adverse Events, Outcome Measures, Baseline Characteristics, and Participant Flow were added in the latest version, along with related document sections.SummaryDifference0.6%

Stay in the know with updates to Talque & Teclistamab Combo in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talque & Teclistamab Combo in Myeloma Clinical Trial page.